Ontology highlight
ABSTRACT: Objective
To elucidate the pathogenesis of dupilumab (Dupixent®)-associated ocular surface disease (DAOSD).Design
Prospective single-center cohort study.Subjects
Twenty patients with moderate-to-severe atopic dermatitis (AD) who received dupilumab and 10 age- and sex-matched healthy controls were enrolled in the study.Methods
The study cohort underwent a thorough slit-lamp and entire-body dermatologic examination. Conjunctival swabs and smears were collected at baseline, 4 and 16 weeks after treatment initiation, and during the conjunctivitis episode. To analyse the ocular surface microbiome, 16S ribosomal RNA sequencing was performed, smears were hematoxylin and eosin stained, and serum cytokines were measured by using a multiplex immunobead assay.Main
SUBMITTER: Patra V
PROVIDER: S-EPMC10585475 | biostudies-literature | 2024 Jan-Feb
REPOSITORIES: biostudies-literature